LONDON, September 29, 2011 /PRNewswire/ --
Pharma IQ recently launched a survey with the objective of creating an easy-to-assimilate summary of serialisation requirements around the world.
Early results of the survey - which is still open - demonstrate that 2D Datamatrix is the serialisation method of choice currently being implemented in major countries and continents. At the moment, 2D Datamatrix is coming up number one, closely followed by 1D barcode Code-128C but on a several number of cases organisations are implementing specific methods depending on the level of serialisation required - "Every packaging level" and "package" among most responses on the latest.
For more information on the survey or to participate visit
This industry wide survey will remain open until the 5th of October, final results to be released to the public late October. The results will also be presented and discussed by industry experts at Pharma IQ's Pharmaceutical Serialisation and Traceability conference taking place from the 2nd - 4th November in Geneva, Switzerland.
Organisations attending the Pharmaceutical Serialisation and Traceability conference include the Uganda Ministry of Health, Abbott, Galexis AG, Novartis V&D srl, Nuceria and Reckitt Benckiser, Mylan Inc, NanoGuardian, Cemelog Zrt.
The programme features presentations from EHIBCC, GS1, GIRP, AstraZeneca, Roche, Agenzia Italiana del Farmaco, Abbott, Italian Ministry of Health, Association of the Pharmacists of Belgium, GSK, Boehringer Ingleheim, Montesino, Blue Sphere Health, DAIICHI SANKYO ILAÇ TICARET Ltd plus many more.
Press are invited to attend this important industry forum, if you would like to a complimentary press pass please email Veronica Araujo ([email protected])
SOURCE Pharma IQ